Diabetes Care 30: , 2007
|
|
|
- Gabriella Howard
- 5 years ago
- Views:
From this document you will learn the answers to the following questions:
Where did the participants come from?
Transcription
1 Clinical Care/Education/Nutrition/Psychosocial Research O R I G I N A L A R T I C L E Effectiveness of a Self-Management Intervention in Patients With Screen- Detected Type 2 Diabetes BART THOOLEN, PHD 1 DENISE DE RIDDER, PHD 1 JOZIEN BENSING, PHD 1,2 CORA MAAS, PHD 3 SIMON GRIFFIN, MD, PHD 4 KEES GORTER, MD, PHD 5 GUY RUTTEN, MD, PHD 5 OBJECTIVE To examine the effectiveness of a theory-driven self-management course in reducing cardiovascular risk in patients with screen-detected type 2 diabetes, taking ongoing medical treatment into account. RESEARCH DESIGN AND METHODS A total of 196 screen-detected patients, receiving either intensive pharmacological or usual-care treatment since diagnosis (3 33 months previously), were subsequently randomized to a control or intervention condition (selfmanagement course). A 2 2 factorial design evaluated the behavioral intervention (selfmanagement course versus control) nested within the medical treatment (intensive versus usual care), using multilevel regression modeling to analyze changes in patients BMI, A1C, blood pressure (BP), and lipid profiles over 12 months, from the start of the 3-month course to 9-month follow-up. RESULTS The self-management course significantly reduced BMI ( 0.77 kg/m 2 ) and systolic BP ( 6.2 mmhg) up until the 9-month follow-up, regardless of medical treatment. However, intensive medical treatment was also independently associated with lower BP, A1C, total cholesterol, and LDL before the course and further improvements in systolic BP ( 4.7 mmhg). Patients receiving both intensive medical treatment and the self-management course therefore had the best outcomes. CONCLUSIONS This self-management course was effective in achieving sustained reductions in weight and BP, independent of medical treatment. A combination of behavioral and medical interventions is particularly effective in reducing cardiovascular risk in newly diagnosed patients. Diabetes Care 30: , 2007 About 200 million people have been diagnosed with type 2 diabetes worldwide. The actual prevalence is believed to be considerably higher, with a large number of patients remaining undiagnosed, untreated, and unaware of their illness and its long-term health consequences. These patients may not feel ill, but the presence of obesity, chronic hyperglycemia, hypertension, and hypercholesterolemia can ultimately result in devastating micro- and macrovascular complications. In recognition, there has been a widespread call for screening programs to detect and treat patients at an earlier stage of their disease, thereby assuming that this will reduce their cardiovascular risk and improve their long-term From the 1 Department of Clinical and Health Psychology, Utrecht University, Utrecht, the Netherlands; 2 NIVEL: Netherlands Institute for Health Services Research, Utrecht, the Netherlands; the 3 Department of Methodology and Statistics, Utrecht University, Utrecht, the Netherlands; the 4 MRC Epidemiology Unit, Cambridge, U.K.; and the 5 Julius Center for Health Sciences and Primary Care, Utrecht, the Netherlands. Address correspondence and reprint requests to Bart Thoolen, Department of Clinical and Health Psychology, Utrecht University, P.O. Box , 3508 TC Utrecht, Netherlands. [email protected]. Received for publication 22 April 2007 and accepted in revised form 20 July Published ahead of print at on 31 July DOI: /dc Abbreviations: BP, blood pressure; ADDITION, Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Type 2 Diabetes in Primary Care. A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances by the American Diabetes Association. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. health (1,2). There is good evidence that intensive treatments combining medication and lifestyle modifications are effective in both the prevention and management of type 2 diabetes (3 5). However, no studies have focused on the effectiveness of such treatments after a screeningbased diagnosis. Furthermore, the success of treatments ultimately depends on patients ability to accept their diagnosis and actively manage their disease. Treatment adherence in patients with type 2 diabetes is notoriously low (6,7). Interventions to improve self-management have had some success in improving patient s lifestyles and also lead to significant reductions in cardiovascular risk factors; however, improvements have generally been small and short-lived, disappearing once intensive contact with professionals is removed (8 10). The challenge therefore remains to develop interventions that help patients to achieve sustained lifestyle change and ultimately decrease their cardiovascular risk. In the present study, we examine the effectiveness of a brief 3-month theorydriven self-management intervention proven effective in helping people with screen-detected type 2 diabetes to achieve a sustained lifestyle change (11; B.T., D.D.R., J.B., K.G., G.R., unpublished data). We now assess whether such an intervention is also effective in reducing cardiovascular risk and how far these improvements can be sustained beyond the program. The unique position of this study within an ongoing medical trial makes it possible to examine the relative effectiveness of the behavioral intervention on top of and apart from intensive medical treatment geared to reducing cardiovascular risk in patients with screendetected diabetes. We hypothesized that the self-management intervention would be most successful among patients receiving standard medical care but would be less effective among intensively treated patients who were already receiving numerous medications to target their metabolic control, blood pressure, and lipid profiles DIABETES CARE, VOLUME 30, NUMBER 11, NOVEMBER 2007
2 Thoolen and Associates Table 1 Demographic and medical characteristics by treatment group (n 196) RESEARCH DESIGN AND METHODS Participants were recruited from the Dutch arm of the ADDI- TION study (Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Type 2 Diabetes in Primary Care), an ongoing multi-center randomized trial evaluating both the feasibility of a population-based screening program for type 2 diabetes and the effectiveness of a target-driven approach to reduce cardiovascular risk in people with screen-detected diabetes (12). Patients (aged years) from participating practices were invited to take part in a stepwise screening from 2002 to 2004, with diagnosis set according to World Health Organization criteria. Practices were randomly assigned to deliver either intensive multifactorial pharmacological treatment or usual care from the moment people were diagnosed. Intensive treatment included target-driven tight control of 1) A1C (oral hypoglycemic agents when A1C was 6.5%, insulin therapy when A1C remained 7.0%), 2) blood pressure (BP) (antihypertensive agents [aspirin and ACE inhibitors] when BP was 120/80 mmhg, stepwise increase when 135/85 mmhg), and 3) cholesterol (statins when plasma cholesterol 3.5 mmol/l). In contrast, usual care followed national guidelines (A1C 8.5% and BP 150/85 mmhg considered acceptable, cholesterol treatment depending on patient s estimated risk of coronary heart disease ( 25%) (13). In 2004, 468 screen-detected patients included in ADDITION and not suffering from serious physical or mental comorbidities were invited to participate in the present study, Beyond Good Intentions. At that point, patients had already been diagnosed 3 33 months previously and Usual-care medical treatment Intensive medical treatment Course Control Course Control n (dropout) 50 (4) (7) 52 Age (mean) Sex Male (%) Female (%) Education level* Disease duration (months) Data are means SD unless otherwise indicated. Subjects include 107 patients in the control group and 89 patients who completed or dropped out of the intervention. *Level of education was measured on a 6-point scale (1 lowest, 6 highest level). had consistently been receiving either intensive or usual-care treatment ever since. Beyond Good Intentions specifically examined whether a self-management intervention could (further) reduce these patients cardiovascular risk. To that end, participants were randomized to a control or intervention group. The control group received a brochure on diabetes selfmanagement. The intervention group received a self-management course. The self-management course lasted 12 weeks, including two (1-h) individual sessions and four (2-h) biweekly group meetings (n 6 8) lead by a trained nurse. During the sessions, various domains of self-care (including diet, exercise, and medication) were discussed, and patients were taught to formulate, plan, and carry out personally relevant goals with regard to each theme using a proactive five-step plan. Based on theories of proactive coping (14) and self-regulation (15), the course emphasized the elements of anticipation, goal setting, planning, and problem solving, helping patients move beyond their intentions to achieve optimal self-care. The development and evaluation of the course has been published previously, indicating that the course was highly effective in helping patients to both initiate and maintain selfcare behaviors up to 9 months after the course (11; B.T., D.D.R., J.B., K.G., G.R., unpublished data). In this article, the focus is on whether such an intervention can improve patients medical outcomes, assessing changes in cardiovascular risk factors over 12 months, from the start of the 3-month course to 9-month follow-up, taking ongoing medical treatment into account. The study was approved by the Ethics Committee of the University Medical Center Utrecht. Sample In total, 227 of the 468 patients (49%) agreed to participate in the study. Participants were more educated than nonparticipants and reported slightly less selfmanagement behavior, but there were no differences with regard to other sociodemographic characteristics or perceptions of diabetes (16). Participants were randomly allocated to the control (n 108) or intervention (n 119) condition. Owing to the widespread geographical area, the course was given at different locations. Nevertheless, 30 patients who wished to participate were unable to attend due to difficulties with transportation and were therefore excluded from the study. At the start, the study thus included 108 patients in the control group and 89 in the intervention group. The course was run 13 times, with an average seven patients per course. Eleven patients dropped out during the course because of personal circumstances (e.g., time, illness, and limited mobility) but were included for intention-to-treat analyses. One patient in the control group was terminally ill, died 2 months into the study, and was excluded from analyses. Patients who were excluded or dropped out were less educated but did not differ significantly from participants with regard to other sociodemographic characteristics or their perceptions of diabetes (16). The baseline characteristics of the final 196 participants are shown in Table 1, differentiated by their allocation in ADDI- TION (intensive or usual-care treatment) and Beyond Good Intentions (control or intervention condition). There were no significant differences between groups with regard to sociodemographic variables, but intensively treated patients were diagnosed more recently than usualcare patients (F 6.2, P 0.05). Given the two phases in the screening procedure (May to December 2002 and June 2003 to May 2004, respectively), most patients were logically diagnosed for 1 or 2 years. Measures Measures including BMI, A1C, systolic and diastolic BP, and lipid profiles, including total, HDL, and LDL cholesterol and triglycerides were retrieved from patient files. The number and dates of measurement varied by patient, coinciding DIABETES CARE, VOLUME 30, NUMBER 11, NOVEMBER
3 Intervention in screen-detected diabetes with their routine checkups but not necessarily with exact start and end points of this study. To maximize the number of measures and reliably estimate the start, end points, and change in between, we included measures taken from time of enrollment, 31 days before the selfmanagement intervention, and up until 3 months beyond the end point at the 9-month follow-up. BMI and BP were recorded an average of 3 times per patient (3.2 and 3, respectively), A1C an average of 3.6 times, and lipid profiles an average of 2 times. Biochemical tests were performed in the regional laboratory A1C by high-performance liquid chromatography and lipid profiles by enzymatic techniques. Analyses A2 2 factorial design evaluated the selfmanagement course (intervention versus control) nested within the medical treatment (intensive versus usual care), using multilevel regression modeling to analyze changes in patients BMI, A1C, BP, and lipid profiles over 12 months, from the start of the 3-month course to 9-month follow-up. Following the intention-totreat procedure, we included all patients participating at the start of the study (including 11 participants who dropped out). Multilevel modeling can be considered a sophisticated regression analysis that takes the nested structure of the data into account (17). In our study, the time point and number of measurements varied per individual, individuals were grouped within different general practices, and individuals were also grouped in different course locations. Multilevel modeling allowed us to make use of all the available information (including the variation in time points) to make a more precise estimation of the regression line and beginning and end points. A preliminary analysis was done for each outcome separately, examining whether outcomes varied over time, individuals, course location, and general practices (data not shown). Taking into account that outcomes may fluctuate in a nonlinear fashion over time, we included both a linear (time) and quadratic function of time (time 2 ). Variances in BMI, A1C, and BP depended on both the time point of measurement and the individual patient. In contrast, variances in lipid profiles depended on time, indicating that these outcomes did not change (consistently) over time. Variance in total, LDL, and HDL cholesterol depended solely on the individual; these outcomes were analyzed using a one-level model examining mean differences between individuals. Finally, variance in triglycerides was dependent on both the individual and practice, indicating that patients from the same practice showed more similarity with each other than with other patients. Analyses of triglycerides therefore took both the individual and practice into account. Subsequent analyses followed traditional regression analyses, taking relevant levels into account. For each dependent variable (cardiovascular risk factor), predictors were entered in the regression equation, step by step. First, sex, education, and disease duration were included, given the differences between groups and/or potential for these variables to influence outcomes. Disease duration was included as a dichotomous variable, with 1.5 years as a median split. Next, we examined the effects of the predictors AD- DITION (intensive versus usual-care treatment) and Beyond (self-management course versus control) on both mean levels and changes in outcomes over time, also including two- and three-way interactions between ADDITION, Beyond, and time. For interpretative purposes, day of measurement was translated into years (e.g., day 365 1). As such, regression coefficients related to time are indicative of relative changes over 1 year, allowing us to predict beginning and end points and mean changes over 1 year in each group of patients, from the start of the course to 9-month follow-up, differentiated by their allocation to the medical treatment and self-management intervention. RESULTS The results of the multilevel regression analyses for each outcome are depicted in Table 2 and described in the text below. To maintain legibility, the table only includes the regression coefficient when significant. To indicate the relative effect of different combinations of treatments, the lower part of the table indicates estimated starting and end points and absolute mean change in outcome over 1 year depending on patients allocation in ADDITION (intensive versus usual care) and Beyond (course versus control). BMI The effect of control variables were examined first. Education and disease duration did not affect BMI, but women showed significantly higher BMI ( 2.07 kg/m 2 ) than men; sex was therefore included in subsequent analysis. The regression analysis indicated that BMI changed over time in a nonlinear fashion, depending on patients allocation to the self-management intervention (Beyond) (Fig. 1). Intervention participants lost a significant amount of weight during the first months of the course, with weight loss gradually tapering off to a net loss of 0.39 BMI by the 9-month follow-up. In contrast, control patients gained weight at an everincreasing rate ( 0.38 BMI), a difference of 0.77 BMI (or 2.6 kg) at the 9-month follow-up. Medical treatment (ADDI- TION) had no effect on mean level or changes in BMI over time. BP Sociodemographic factors and disease duration had no significant main effects on systolic or diastolic BP, but before the self-management intervention, intensively treated patients already had a significantly lower BP than usual-care patients ( 6.7 mmhg systolic and 4.2 mmhg diastolic BP). With regard to systolic BP, outcomes changed over time in a nonlinear fashion, depending on patients allocation to the behavioral and medical interventions, indicated by a significant interaction effect of Beyond time (B 6.2, P 0.05) and a marginal effect of ADDITION time (B 4.6, P 0.06) (Fig. 1). Without any additional care, patients systolic BP gradually increased over 12 months to 4.9 mmhg by the 9-month follow-up. Taken separately, both the intensive medical treatment and the self-management course were effective in reducing BP, but BP tended to revert to baseline levels by the 9-month follow-up. In contrast, patients receiving both intensive medical treatment and the self-management course achieved significant and sustained reductions in their systolic BP: a net decrease of 5.9 mmhg and a difference of 10.8 mmhg with those patients receiving no additional care. With regard to diastolic BP, there was no main effect of time, and neither ADDI- TION nor Beyond significantly influenced changes over time. A1C Sociodemographic factors and disease duration had no significant main effects on A1C, but patients receiving intensive medical treatment had a significantly lower A1C ( 0.27) (ADDITION). A1C 2834 DIABETES CARE, VOLUME 30, NUMBER 11, NOVEMBER 2007
4 Thoolen and Associates Table 2 Effectiveness of a self-management intervention (Beyond: course 1 versus control 0 ) on top of and next to intensive medical treatment (ADDITION: intensive 1 versus usual-care 0 treatment) BMI BP Cholesterol Systolic Diastolic Total A1C HDL LDL Triglycerides Predictors Number of measures Mean per patient SD Constant Sex (male 1) 2.07 NS NS NS * NS Education NS NS NS NS NS NS NS NS Duration NS NS NS NS NS NS 0.18* NS Time 0.34 NS 7.6 NS NS 0.55 Time * 12.5 NS 0.57 ADDITION NS NS 0.54 NS ADDITION time NS 4.6 NS 0.70 ADDITION time 2 NS NS NS 0.60 Beyond 0.27 NS 0.9 NS NS NS NS NS NS NS Beyond time * NS NS Beyond time 2 NS NS NS NS Mean estimated starting levels differentiated by medical treatment and self-management condition ADDITION beyond Usual care control Usual care course Intensive control Intensive course Mean year change in outcomes differentiated by medical treatment and self-management condition ADDITION beyond Usual care control Usual care course Intensive control Intensive course Mean estimated levels at 9-month follow-up differentiated by medical treatment and self-management condition ADDITION beyond Usual care control Usual care course Intensive control Intensive course A multilevel regression analysis of change in cardiovascular outcomes over 12 months, from the start of the 3-month course to 9-month follow-up, reported in terms of significant B values. *P 0.05, P 0.01, P 0.001, P Two- and three-way interactions between ADDITION and Beyond were not significant. BMI, A1C, and BP were based on two-level models including person and time. HDL, LDL, and total cholesterol were based on the one-level model, including the person. Triglyceride was based on a two-level model including the general practitioner and the person. NS, not significant. levels varied over time in a nonlinear fashion, depending on patients medical treatment, with both usual and intensively treated patients showing slight increases in A1C (0.02 and 0.12, respectively). In both groups, however, levels remained in the normal healthy range (6.34 and 6.17, respectively, for the usual and intensively treated group). The self-management intervention (Beyond) had no effects on mean levels or changes in A1C. Lipid profiles Preliminary analyses revealed that lipid profiles did not vary significantly over time; hence, analyses were limited to mean differences. Females showed significantly higher total, HDL, and LDL cholesterol than men, and patients with longer disease duration reported a significantly higher LDL. Patients receiving intensive medical treatment had significantly lower total cholesterol ( 0.60, P 0.001) and LDL levels ( 0.54, P 0.001) than patients receiving usual treatment, but they did not differ with regard to either HDL or triglyceride levels. The self-management intervention (Beyond) had no effects on lipid profiles. CONCLUSIONS This study suggests that a self-management intervention can be effective in improving cardiovascular risk in screen-detected patients recently diagnosed with type 2 diabetes, both on top of and apart from intensive medical treatment. The fact that the course achieved these changes in patients who had already experienced considerable improvements in their cardiovascular risk factors further emphasizes the effectiveness of this theory-driven selfmanagement course and the potential for lifestyle interventions in general to make a difference in diabetes care. The self-management intervention led to significant weight loss and important decreases in systolic BP that were maintained up to 9 months after the intervention ceased. With regard to weight change, we found that, regardless of medical treatment, patients in the control condition gained weight, while patients in the intervention condition lost weight, leading to a difference in BMI of 0.77 kg/m 2 or 2.6 kg in 1 year, a difference that continued to increase. While such differences may appear relatively small, until now, few other interventions have successfully DIABETES CARE, VOLUME 30, NUMBER 11, NOVEMBER
5 Intervention in screen-detected diabetes Figure 1 Changes in BMI and systolic BP by treatment: Beyond (course vs. control) by ADDITION (intense vs. usual). been able to make a difference once contact is removed (8,9). Weight loss appears to be one area in which behavioral interventions can be more effective than a medical approach. Furthermore, the selfmanagement intervention was more effective than medical treatment with regard to systolic BP. Despite the initial successes of the intensive medical treatment, systolic BP tended to increase by the end of this study in both usual-care and intensively treated patients. A combination of intensive medical treatment and the self-management course proved to be most effective; patients who received both interventions ultimately had a mean systolic BP of mmhg at the 9-month follow-up, compared with mmhg for patients receiving only usual care. These results are even more encouraging when one considers that the course was relatively brief and given by a minimally trained nurse in the patient s local environment. Previous evaluations of the course have indicated that its theoretical underpinnings, notably the combination of goal setting, planning, and anticipation, were very successful in helping patients to initiate and maintain small changes in their self-management behaviors, diet, and exercise in particular (11; B.T., D.D.R., J.B., K.G., G.R., unpublished data). However, those findings were based on patients self-reports. This study provides some more objective evidence that such a theory-based intervention can indeed help patients to achieve improvements. Recent meta-analyses suggest that self-management interventions relying on goal setting and planning are particularly effective (18). We would suggest that anticipation is another important ingredient. Patients will be more likely to achieve their self-management goals when they recognize barriers to and conditions for goal attainment and consider alternative strategies beforehand and how they will evaluate their progress. The concept of proactive coping has been implemented to help patients with a wide range of conditions to deal with potential problems before they arise (19 21). This study suggests that it can also be effective in diabetes management. That said, the effectiveness of the selfmanagement intervention with regard to other cardiovascular risk factors was limited. For that matter, other psychological interventions have had only limited effects in improving metabolic control or lipid profiles (8). In this study, the potential for change was limited given the relatively healthy mean levels of cardiovascular outcomes in both medical treatment arms. This, in part, reflects the success of medical treatment that these screen-detected patients received after diagnosis; patients in the intensive arm of ADDITION already showed significantly better outcomes with regard to BP, A1C, and total and LDL cholesterol at baseline, while mean A1C in both medical treatments was 6.5%. Nevertheless, this study suggests that a self-management course can confer additional benefit, independent of medical treatment. The present study had a number of limitations. First, this study relied on a population who was already taking part in a medical intervention in which half did not participate. A detailed comparison of the recruitment and retention process indicated that nonparticipants and dropouts primarily had practical reasons, while education level was the primary variable differentiating between participants, nonparticipants, and dropouts (16). We controlled for this in our analyses but found that education did not significantly influence cardiovascular risk factors. A second issue was our reliance on patient files with the number and time points of measurements varying considerably and depending on patients visits to the general practitioner and laboratory. Multilevel techniques helped to overcome these limitations in our data, allowing us to take these variations into account and base our analyses on existing data rather than imputing missing data that can produce considerable errors in estimation (17). Nevertheless, we did not have measurements for all patients in the 3 months in which the intervention took place (potentially the most effective period). As 2836 DIABETES CARE, VOLUME 30, NUMBER 11, NOVEMBER 2007
6 such, our findings give a good indication of net change over 1 year, but improvements that may have been achieved during the intervention are more obscure. The use of multilevel modeling also allowed us to control for potential influences of patients general practices on outcomes. We found that patients from the same practice were not more similar to each other with regard to most cardiovascular outcomes. In fact, triglycerides were the only outcome influenced by general practice. In sum, our strict adherence to statistical procedures and our consideration of multiple levels allows us to conclude with a high degree of certainty that the self-management intervention was successful in helping patients to reduce their weight and systolic BP. From this perspective, this selfmanagement intervention can be a valuable addition to medical treatments no matter how intensive, particularly when it is taken into account that the course also increased patients awareness, confidence, and self-management behaviors (diet and exercise in particular) (11; B.T., D.D.R., J.B., K.G., G.R., unpublished data). This study suggests that intensive medical treatments may be effective for a while, but gradual relapses in weight, BP, and A1C suggest that additional support may be needed to help patients maintain and achieve further improvements. This study supports a growing body of evidence that self-management interventions can be effective when they have a sound theoretical basis. Acknowledgments The Dutch National Diabetes Fund funded this study. The Stichting Huisartsen Laboratory in Etten-Leur assisted with data collection and course implementation. References 1. Borch-Johnsen KLT: Screening for type 2 diabetes: should it be now? Diabet Med 20: , Engelgau MM, Narayan KM, Herman WH: Screening for type 2 diabetes. Diabetes Care 23: , Gillies CL, Abrams KR, Lambert PC, Cooper JN, Sutton AJ, Hsu RT, Khunti K: Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 299:334, Gaede P, Vedel P, Parving H: Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet 353: , Olivarius NDF, Beck-Nielsen H Andreasen AH, Hørder M, Pedersen PA: Randomised controlled trial of structured personal care of type 2 diabetes mellitus. BMJ 323: , Glasgow RE, Eakin E: Issues in diabetes self-management. In Handbook of Health Behavior. 2nd ed. Schumaker SA, Schron EB, Eds. New York, Springer, 1998, p Peyrot M, Rubin RR, Lauritzen T, Snoek F, Matthews D, Skovlund S, the International DAWN Advisory Panel: Psychosocial problems and barriers to improved diabetes management: results of the cross-national Diabetes Attitudes, Wishes and Needs (DAWN) study. Diabet Med 22: , Norris SL, Engelgau MM, Venkat Narayan KM: Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. Diabetes Care 24: , Ishmail K, Winkley K, Rabe-Jesketh S: Systematic review and meta-analyses of randomized controlled trials of psychological interventions to improve glycaemic control in patients with type-2 diabetes. Lancet 363: , Goudswaard AN, Stolk RP, Zuithoff PA, de Valk HW, Rutten GEHM: Long-term effects of self-management education for patients with type 2 diabetes taking maximal oral hypoglycaemic therapy: a randomized trial in primary care. Diabet Med 21: , Thoolen BJ, De Ridder DTD, Bensing JM, Gorter KJ, Rutten GE: Beyond good intentions: the development and evaluation of a proactive self-management course for patients recently diagnosed with type-2 Thoolen and Associates diabetes. Health Education Research. 7 February 2007 [Epub ahead of print] 12. Lauritzen T, Griffin S, Borch-Johnsen K, Wareham NJM, Wolffenbuttel BH: The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with type 2 diabetes detected by screening. Int J Obes Relat Metab Disord 24:S6 S11, Rutten GEHM, de Graauw WJC, Nijpels G, Goudswaard AN, Uitewall PJM, van der Does FEE, Heine RJ, van Ballegooie E, Verduijn MM, Bouma M: NHG-standard diabetes mellitus type 2. Huisarts Wet 49: , Aspinwall LG, Taylor SE: A stitch in time: self-regulation and proactive coping. Psychol Bull 121: , Carver CS, Scheier MF: On the Self-Regulation of Behavior. Cambridge, U.K., Cambridge University Press, Thoolen BJ, De Ridder DTD, Bensing JM, Gorter KJ, Rutten GE: Who participates in diabetes self-management interventions? Issues of recruitment and retainment. Diabetes Educ 37: , Hox JJ: Multilevel Analysis: Techniques and Applications. Mahweh, NJ, Erlbaum, Norris SL, Zhang X, Avenell A, Gregg E, Brown TJ, Schmid CH, Lau J: Long-term non-pharmacological weight loss interventions for adults with type 2 diabetes mellitus. Cochrane Database Syst Rev. Issue 2. Art. No.: CD004095, DOI: / CD pub2, Aspinwall LG: The psychology of futureoriented thinking: from achievement to proactive coping, adaptation and aging. Motivation and Emotion 29: , Schreurs KMG, Colland VT, Kuijer RG, De Ridder DTD, Den Elderen T: Development, content and process evaluation of a short self-management intervention in patients with chronic diseases requiring self-care behaviours. Patient Educ Couns 53: , Boe C, de Ridder DTD, Kuijer RG, Bensing JM: Effects of an intervention promoting proactive coping competencies in middle and late adulthood. Gerontologist 47:42 51, 2007 DIABETES CARE, VOLUME 30, NUMBER 11, NOVEMBER
ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes
ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes Effects of a fixed combination of the ACE inhibitor, perindopril,
Jill Malcolm, Karen Moir
Evaluation of Fife- DICE: Type 2 diabetes insulin conversion Article points 1. Fife-DICE is an insulin conversion group education programme. 2. People with greater than 7.5% on maximum oral therapy are
Guidelines for the management of hypertension in patients with diabetes mellitus
Guidelines for the management of hypertension in patients with diabetes mellitus Quick reference guide In the Eastern Mediterranean Region, there has been a rapid increase in the incidence of diabetes
CHAPTER V DISCUSSION. normal life provided they keep their diabetes under control. Life style modifications
CHAPTER V DISCUSSION Background Diabetes mellitus is a chronic condition but people with diabetes can lead a normal life provided they keep their diabetes under control. Life style modifications (LSM)
TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D.
TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION Robert Dobbins, M.D. Ph.D. Learning Objectives Recognize current trends in the prevalence of type 2 diabetes. Learn differences between type 1 and type
BIAsp30 A 1 chieve Tehran 31 July 2015
BIAsp30 A 1 chieve Tehran 31 July 2015 Beginning insulin with biphasic insulin aspart 30: experience from the A 1 chieve study Professor Philip Home Newcastle University Presenter and sponsor duality of
The Economic Impact and Cost-Effectiveness of Glucose Monitoring
The Economic Impact and Cost-Effectiveness of Glucose Monitoring William H. Herman, MD, MPH Stefan S. Fajans/GlaxoSmithKline Professor of Diabetes Professor of Internal Medicine and Epidemiology University
Cardiovascular Disease in Diabetes
Cardiovascular Disease in Diabetes Where Do We Stand in 2012? David M. Kendall, MD Distinguished Medical Fellow Lilly Diabetes Associate Professor of Medicine University of MInnesota Disclosure - Duality
DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD
STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with
Protein Intake in Potentially Insulin Resistant Adults: Impact on Glycemic and Lipoprotein Profiles - NPB #01-075
Title: Protein Intake in Potentially Insulin Resistant Adults: Impact on Glycemic and Lipoprotein Profiles - NPB #01-075 Investigator: Institution: Gail Gates, PhD, RD/LD Oklahoma State University Date
The Canadian Association of Cardiac
Reinventing Cardiac Rehabilitation Outside of acute care institutions, cardiovascular disease is a chronic, inflammatory process; the reduction or elimination of recurrent acute coronary syndromes is a
Treating Patients with PRE-DIABETES David Doriguzzi, PA-C First Valley Medical Group. Learning Objectives. Background. CAPA 2015 Annual Conference
Treating Patients with PRE-DIABETES David Doriguzzi, PA-C First Valley Medical Group Learning Objectives To accurately make the diagnosis of pre-diabetes/metabolic syndrome To understand the prevalence
Barriers to Healthcare Services for People with Mental Disorders. Cardiovascular disorders and diabetes in people with severe mental illness
Barriers to Healthcare Services for People with Mental Disorders Cardiovascular disorders and diabetes in people with severe mental illness Dr. med. J. Cordes LVR- Klinikum Düsseldorf Kliniken der Heinrich-Heine-Universität
Main Effect of Screening for Coronary Artery Disease Using CT
Main Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High risk Patients with Diabetes: The FACTOR-64 Randomized Clinical Trial Joseph B. Muhlestein,
Managing diabetes in the post-guideline world. Dr Helen Snell Nurse Practitioner PhD, FCNA(NZ)
Managing diabetes in the post-guideline world Dr Helen Snell Nurse Practitioner PhD, FCNA(NZ) Overview Pathogenesis of T2DM Aims of treatment The place of glycaemic control Strategies to improve glycaemic
Bipolar Disorder and Substance Abuse Joseph Goldberg, MD
Diabetes and Depression in Older Adults: A Telehealth Intervention Julie E. Malphurs, PhD Asst. Professor of Psychiatry and Behavioral Science Miller School of Medicine, University of Miami Research Coordinator,
Obesity in the United States Workforce. Findings from the National Health and Nutrition Examination Surveys (NHANES) III and 1999-2000
P F I Z E R F A C T S Obesity in the United States Workforce Findings from the National Health and Nutrition Examination Surveys (NHANES) III and 1999-2000 p p Obesity in The United States Workforce One
Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes
Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes U.S. Department of Health and Human Services Food and Drug Administration Center
Clinical Research on Lifestyle Interventions to Treat Obesity and Asthma in Primary Care Jun Ma, M.D., Ph.D.
Clinical Research on Lifestyle Interventions to Treat Obesity and Asthma in Primary Care Jun Ma, M.D., Ph.D. Associate Investigator Palo Alto Medical Foundation Research Institute Consulting Assistant
Cardiovascular risk assessment: Audit findings from a nurse clinic a quality improvement initiative
Cardiovascular risk assessment: Audit findings from a nurse clinic a quality improvement initiative Sarah Waldron RN, PG Dip (Adv Ng); Margaret Horsburgh RN, EdD, MA (Hons), Dip Ed, FCNA(NZ) School of
Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007
Metabolic Syndrome Overview: Easy Living, Bitter Harvest Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Evolution of Metabolic Syndrome 1923: Kylin describes clustering
Understanding diabetes Do the recent trials help?
Understanding diabetes Do the recent trials help? Dr Geoffrey Robb Consultant Physician and Diabetologist CMO RGA UK Services and Partnership Assurance AMUS 25 th March 2010 The security of experience.
How To Determine The Prevalence Of Microalbuminuria
Research Journal of Pharmaceutical, Biological and Chemical Sciences Prevalence of Microalbuminuria in relation to HbA1c among known Type2 Diabetic Patients in Puducherry population Muraliswaran P 1 *,
Undetected diabetes may be as prevalent
Epideminology/Health Services/Psychosocial Research O R I G I N A L A R T I C L E Cost-Effectiveness Analysis of Different Screening Procedures for Type 2 Diabetes The KORA Survey 2000 ANDREA ICKS, MD,
DIABETES DISEASE MANAGEMENT PROGRAM DESCRIPTION FY11 FY12
DIABETES DISEASE MANAGEMENT PROGRAM DESCRIPTION FY11 FY12 TABLE OF CONTENTS 1. INTRODUCTION.3 2. SCOPE........3 3. PROGRAM STRUCTURE...4 3.1. General Educational Interventions.....4 3.2. Identification
Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines)
Cardiovascular Health Nova Scotia Guideline Update Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines) Authors: Dr. M. Love, Kathy Harrigan Reviewers:
BACKGROUND. ADA and the European Association recently issued a consensus algorithm for management of type 2 diabetes
BACKGROUND More than 25% of people with diabetes take insulin ADA and the European Association recently issued a consensus algorithm for management of type 2 diabetes Insulin identified as the most effective
Baskets of Care Diabetes Subcommittee
Baskets of Care Diabetes Subcommittee Disclaimer: This background information is not intended to be a comprehensive scientific discussion of the topic, but rather an attempt to provide a baseline level
Absolute cardiovascular disease risk assessment
Quick reference guide for health professionals Absolute cardiovascular disease risk assessment This quick reference guide is a summary of the key steps involved in assessing absolute cardiovascular risk
Hypertension Best Practices Symposium
essentia health: east region 1 Hypertension Best Practices Symposium RN Hypertension Management Pilot Essentia Health: East Region Duluth, MN ORGANIZATION PROFILE Essentia Health is an integrated health
How To Know If You Have Microalbuminuria
3 PREVALENCE AND PREDICTORS OF MICROALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A CROSS-SECTIONAL OBSERVATIONAL STUDY Dr Ashok S Goswami *, Dr Janardan V Bhatt**; Dr Hitesh Patel *** *Associate
The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery
The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery Michael E. Farkouh, MD, MSc Peter Munk Chair in Multinational Clinical Trials Director, Heart and Stroke
How To Treat Dyslipidemia
An International Atherosclerosis Society Position Paper: Global Recommendations for the Management of Dyslipidemia Introduction Executive Summary The International Atherosclerosis Society (IAS) here updates
Concept Series Paper on Disease Management
Concept Series Paper on Disease Management Disease management is the concept of reducing health care costs and improving quality of life for individuals with chronic conditions by preventing or minimizing
Preservation and Incorporation of Valuable Endoscopic Innovations (PIVI)
Preservation and Incorporation of Valuable Endoscopic Innovations (PIVI) The American Society for Gastrointestinal Endoscopy PIVI on Endoscopic Bariatric Procedures (short form) Please see related White
Chapter 8 - General Discussion
Chapter 8 - General Discussion 101 As stated in the introduction, the goal of type 2 diabetes care is to offer patients an integrated set of interventions in relation to life style, blood pressure regulation,
Diabetes and Heart Disease
Diabetes and Heart Disease Diabetes and Heart Disease According to the American Heart Association, diabetes is one of the six major risk factors of cardiovascular disease. Affecting more than 7% of the
GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY*
71 GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY* Ryuichi KIKKAWA** Asian Med. J. 44(2): 71 75, 2001 Abstract: Diabetic nephropathy is the most devastating complication of diabetes and is now the
Hôpitaux Universitaires de Genève Lipides, métabolisme des hydrates de carbonne et maladies cardio-vasculaires
Hôpitaux Universitaires de Genève Lipides, métabolisme des hydrates de carbonne et maladies cardio-vasculaires Prof. J. Philippe Effect of estrogens on glucose metabolism : Fasting Glucose, HbA1c and C-Peptide
Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria.
Kidney Complications Diabetic Nephropathy Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. The peak incidence of nephropathy is usually 15-25 years
THE NHS HEALTH CHECK AND INSURANCE FREQUENTLY ASKED QUESTIONS
THE NHS HEALTH CHECK AND INSURANCE FREQUENTLY ASKED QUESTIONS Introduction The following document has been produced by the Department of Health in partnership with the Association of British Insurers,
CARE MANAGEMENT FOR LATE LIFE DEPRESSION IN URBAN CHINESE PRIMARY CARE CLINICS
CARE MANAGEMENT FOR LATE LIFE DEPRESSION IN URBAN CHINESE PRIMARY CARE CLINICS Dept of Public Health Sciences February 6, 2015 Yeates Conwell, MD Dept of Psychiatry, University of Rochester Shulin Chen,
Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital
Research Article Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital *T. JANAGAN 1, R. KAVITHA 1, S. A. SRIDEVI
Scottish Diabetes Survey 2013. Scottish Diabetes Survey Monitoring Group
Scottish Diabetes Survey 2013 Scottish Diabetes Survey Monitoring Group Contents Contents... 2 Foreword... 4 Executive Summary... 6 Prevalence... 8 Undiagnosed diabetes... 18 Duration of Diabetes... 18
HeartScore Web - based version users guide TABLE OF CONTENTS. 1. Preamble... 2. 2. Benefits of using HeartScore... 2. 3. Accessing HeartScore...
TABLE OF CONTENTS 1. Preamble... 2 2. Benefits of using HeartScore... 2 3. Accessing HeartScore... 2 4. HeartScore Web Based Homepage... 3 5. Patient Card... 4 6. Create a new examination... 6 7. Examination
The first endoscopically-delivered device therapy for obese patients with type 2 diabetes
DIABETES WEIGHT ENDOBARRIER THERAPY The first endoscopically-delivered device therapy for obese patients with type 2 diabetes Restore the metabolic health of your patients with EndoBarrier Therapy. Dual
Type 2 Diabetes workshop notes
Group 1 notes Abi / Nicole Type 2 Diabetes workshop notes 4.1 Population The group discussed the following sub groups that may need addressing: Men-as they tend to die earlier compared with women, their
Diabetes: Factsheet. Tower Hamlets Joint Strategic Needs Assessment 2010-2011. Executive Summary. Recommendations
Diabetes: Factsheet Tower Hamlets Joint Strategic Needs Assessment 2010-2011 Executive Summary Diabetes is a long term condition that affects 11,859 people in Tower Hamlets, as a result of high levels
Appendix: Description of the DIETRON model
Appendix: Description of the DIETRON model Much of the description of the DIETRON model that appears in this appendix is taken from an earlier publication outlining the development of the model (Scarborough
Population Health Management Program
Population Health Management Program Program (formerly Disease Management) is dedicated to improving our members health and quality of life. Our Population Health Management Programs aim to improve care
MY TYPE 2 DIABETES NUMBERS
BLOOD SUGAR MANAGEMENT GUIDE MY TYPE 2 DIABETES NUMBERS Understanding and Tracking the ABCs of Type 2 Diabetes 1 BLOOD MY TYPE SUGAR 2 DIABETES MANAGEMENT ABC NUMBERS GUIDE When you have type 2 diabetes,
Statins and Risk for Diabetes Mellitus. Background
Statins and Risk for Diabetes Mellitus Kevin C. Maki, PhD, FNLA Midwest Center for Metabolic & Cardiovascular Research and DePaul University, Chicago, IL 1 Background In 2012 the US Food and Drug Administration
Coronary Heart Disease (CHD) Brief
Coronary Heart Disease (CHD) Brief What is Coronary Heart Disease? Coronary Heart Disease (CHD), also called coronary artery disease 1, is the most common heart condition in the United States. It occurs
Robert Okwemba, BSPHS, Pharm.D. 2015 Philadelphia College of Pharmacy
Robert Okwemba, BSPHS, Pharm.D. 2015 Philadelphia College of Pharmacy Judith Long, MD,RWJCS Perelman School of Medicine Philadelphia Veteran Affairs Medical Center Background Objective Overview Methods
Insulin initiation in type 2 diabetes: Experience and insights
Insulin initiation in type 2 diabetes: Experience and insights Joan Everett A diagnosis of type 2 diabetes can be devastating for the individual and their family. Furthermore, many people with diabetes
Trends in Prescribing of Drugs for Type 2 Diabetes in General Practice in England (Chart 1) Other intermediate and long-acting insulins
Type 2 Diabetes Type 2 diabetes is the most common form of diabetes, accounting for 90 95% of cases. 1 Charts 1 and 2 reflect the effect of increasing prevalence on prescribing and costs of products used
EXPANDING THE EVIDENCE BASE IN OUTCOMES RESEARCH: USING LINKED ELECTRONIC MEDICAL RECORDS (EMR) AND CLAIMS DATA
EXPANDING THE EVIDENCE BASE IN OUTCOMES RESEARCH: USING LINKED ELECTRONIC MEDICAL RECORDS (EMR) AND CLAIMS DATA A CASE STUDY EXAMINING RISK FACTORS AND COSTS OF UNCONTROLLED HYPERTENSION ISPOR 2013 WORKSHOP
Diabetes Complications
Managing Diabetes: It s s Not Easy But It s s Worth It Presenter Disclosures W. Lee Ball, Jr., OD, FAAO (1) The following personal financial relationships with commercial interests relevant to this presentation
Role of Body Weight Reduction in Obesity-Associated Co-Morbidities
Obesity Role of Body Weight Reduction in JMAJ 48(1): 47 1, 2 Hideaki BUJO Professor, Department of Genome Research and Clinical Application (M6) Graduate School of Medicine, Chiba University Abstract:
1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME
1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME Izet Aganović, Tina Dušek Department of Internal Medicine, Division of Endocrinology, University Hospital Center Zagreb, Croatia 1 Introduction The metabolic syndrome
Investigation of the effect of isomaltulose (PalatinoseTM) on metabolic parameters in subjects with Type 2 Diabetes.
PLEASE NOTE: This trial has been registered retrospectively. Trial Description Title Investigation of the effect of isomaltulose (PalatinoseTM) on metabolic parameters in subjects with Type 2 Diabetes.
Upstate New York adults with diagnosed type 1 and type 2 diabetes and estimated treatment costs
T H E F A C T S A B O U T Upstate New York adults with diagnosed type 1 and type 2 diabetes and estimated treatment costs Upstate New York Adults with diagnosed diabetes: 2003: 295,399 2008: 377,280 diagnosed
High Blood Cholesterol
National Cholesterol Education Program ATP III Guidelines At-A-Glance Quick Desk Reference 1 Step 1 2 Step 2 3 Step 3 Determine lipoprotein levels obtain complete lipoprotein profile after 9- to 12-hour
Drug Treatment in Type 2 Diabetes with Hypertension
Hypertension is 1.5 2 times more prevalent in Type 2 diabetes (prevalence up to 80 % in diabetic subjects). This exacerbates the risk of cardiovascular disease by ~ two-fold. Drug therapy reduces the risk
Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results
Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Paul K. Whelton, MB, MD, MSc Chair, SPRINT Steering Committee Tulane University School of Public Health and Tropical Medicine, and
Glycemic Control of Type 2 Diabetes Mellitus
Bahrain Medical Bulletin, Vol. 28, No. 3, September 2006 Glycemic Control of Type 2 Diabetes Mellitus Majeda Fikree* Baderuldeen Hanafi** Zahra Ali Hussain** Emad M Masuadi*** Objective: To determine the
Second- and Third-Line Approaches for Type 2 Diabetes Workgroup: Topic Brief
Second- and Third-Line Approaches for Type 2 Diabetes Workgroup: Topic Brief March 7, 2016 Session Objective: The objective of this workshop is to assess the value of undertaking comparative effectiveness
Chronic Disease and Nursing:
Chronic Disease and Nursing: A Summary of the Issues What s the issue? Chronic diseases are now the major global disease problem facing the world and a key barrier to development, to alleviating poverty,
Summary Evaluation of the Medicare Lifestyle Modification Program Demonstration and the Medicare Cardiac Rehabilitation Benefit
The Centers for Medicare & Medicaid Services' Office of Research, Development, and Information (ORDI) strives to make information available to all. Nevertheless, portions of our files including charts,
Measuring and Improving the Quality of Diabetes care in General Practice. Dr M Grixti. Dr C Scalpello, Dr C Mercieca, Dr P Mangion, Dr T O Sullivan
Measuring and Improving the Quality of Diabetes care in General Practice Dr M Grixti. Dr C Scalpello, Dr C Mercieca, Dr P Mangion, Dr T O Sullivan Outline of presentation Statistics Diabetes care,as the
Technology Assessment
Technology Assessment Lifestyle Interventions for Four Conditions: Type 2 Diabetes, Metabolic Syndrome, Breast Cancer, and Prostate Cancer Technology Assessment Program Prepared for: Agency for Healthcare
chapter 1 Chapter 2 chapter 3
SUMMARY summary Theaimofthisthesiswastodescribethedevelopmentandevaluationofanindividual basedlifestyleinterventionamongworkersintheconstructionindustrywithanelevated risk of cardiovascular disease (CVD).
HDL Cholesterol Subfractions and the Effect of Testosterone Replacement in Hypogonadism
HDL Cholesterol Subfractions and the Effect of Testosterone Replacement in Hypogonadism E. Bolu 1, A. Sonmez 1, S. Tapan 2, A. Taslipinar 1, A. Aydogdu 1, C. Meric 1, Y. Basaran 1, G. Uckaya 1, M. Serdar
Diabetes Mellitus. Melissa Meredith M.D. Diabetes Mellitus
Melissa Meredith M.D. Diabetes mellitus is a group of metabolic diseases characterized by high blood glucose resulting from defects in insulin secretion, insulin action, or both Diabetes is a chronic,
Research. Efficacy of intensive multitherapy for patients with type 2 diabetes mellitus: a randomized controlled trial
Efficacy of intensive multitherapy for patients with type 2 diabetes mellitus: a randomized controlled trial Julie Ménard, Hélène Payette, Jean-Patrice Baillargeon, Pierre Maheux, Serge Lepage, Daniel
David Shu, MD, FRCPC Endocrinology, Royal Columbian Hospital October 8 th, 2010
David Shu, MD, FRCPC Endocrinology, Royal Columbian Hospital October 8 th, 2010 Objectives At the end of the talk, the participants will be able to: 1. Identify the increasing prevalence of type 2 diabetes
